The treatment of primary sclerosing cholangitis is a major challenge. Complications such as dominant bile duct stenoses and biliary infections are associated with poor outcomes. Data from a new prospective study with a follow-up of 20 years now show that dominant stenosis and fungal, but not bacterial infections reduce survival free of liver transplantation.
References
Hoffmann, C. E. E. Verschluβ der Gallenwege durch Verdickung der Wandungen. Arch. Pathol. Anat. Physiol. Klin. Med. 49, 206–215 (1867).
Tischendorf, J. J., Hecker, H., Krüger, M., Manns, M. P. & Meier, P. N. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study. Am. J. Gastroenterol. 102, 107–114 (2007).
Tischendorf, J. J. et al. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis. Scand. J. Gastroenterol. 41, 1227–1234 (2006).
Angulo, P. & Lindor, K. D. Primary sclerosing cholangitis. Hepatology 30, 325–332 (1999).
Wiesner, R. H. et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 10, 430–436 (1989).
Rudolph, G. et al. Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J. Hepatol. 51, 149–155 (2009).
Bjornsson, E. & Olsson, R. Dominant strictures in patients with primary sclerosing cholangitis—revisited. Am. J. Gastroenterol. 99, 2281 (2004).
Pohl, J., Ring, A., Stremmel, W. & Stiehl, A. The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis. Eur. J. Gastroenterol. Hepatol. 18, 69–74 (2006).
Vera, A. et al. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet 360, 1943–1944 (2002).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Tischendorf, J., Schirin-Sokhan, R. The importance of treating stenoses and infections. Nat Rev Gastroenterol Hepatol 6, 691–692 (2009). https://doi.org/10.1038/nrgastro.2009.181
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2009.181
- Springer Nature Limited